Clinical Trials
An Oral GLP-1 That Survives the Gut Just Long Enough
Peptide drugs don't usually survive stomach acid or cross the intestinal wall. Isthmus Biosciences says a transient permeation enhancer, not a new peptide, is what finally made an oral GLP-1 agonist work in Phase 2.